Scientists have found a new treatment for people with asthma and chronic obstructive pulmonary disease (COPD) that may be more effective than current options. Over the past 50 years, treatment options ...
Mona Bafadhel receives funding from the National Institute of Health Research, Asthma+Lung UK, and Horizon Europe. For this study, Mona Bafadhel received funding from AstraZeneca to complete the study ...
St. Luke’s Medical Center Global City has established its Inhaler Clinic Service to optimize the care of patients managing pulmonary disorders such as asthma and Chronic Obstructive Pulmonary Disease ...
St. Luke’s Medical Center (SLMC) has opened an inhaler clinic service specifically designed to cater to patients with ...
India Today on MSN
Toxic air spike sends asthma & COPD drug sales soaring to 3-year high
The toxic haze that blanketed large parts of India in November didn't just cloud the skies—it pushed sales of asthma and COPD medicines to their highest levels in three years.
India has the second-highest incidence of chronic obstructive pulmonary disease (CoPD) in the world, after China. What you need to know about CoPD and the cost of treatment for the chronic lung ...
The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD flare-ups seen in 50 years, following promising clinical trial data.
Hosted on MSN
First new treatment for asthma attacks in 50 years
An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%. The findings, published in The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback